Recruiting OBSERVATIONAL NCT04741906
Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication
Sponsor: Amgen
Conditions
Cancer Implants Missing Teeth Osteoporosis
Interventions
Dental implant surgery Prosthetic treatment
Updated 4 times since 2021 Last updated: Aug 20, 2024 Started: Aug 1, 2017 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Cancer and Implants, this trial is actively recruiting participants. The trial is conducted by Amgen and has accumulated 4 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2022 — Jul 2024 [monthly]
Recruiting
-
Mar 2021 — Sep 2022 [monthly]
Recruiting
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Amgen
- Copenhagen University Hospital at Herlev
- Institut Straumann AG
Data source: Copenhagen University Hospital at Herlev
For direct contact, visit the study record on ClinicalTrials.gov .